Heart House Research Foundation, LLC

Springfield, Ohio 45505

1 studies enrolling now · 4 studies all time

What they study most

Atrial Fibrillation, Paroxysmal Supraventricular Tachycardia, Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Stroke

Studies at this site

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 — Stopped early
• Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). — Stopped early
• GLORIA-AF Registry Program - Second and Third Phases — Completed